Arii Shigeki, Teramoto Kennichi, Kawamura Toru, Takamatsu Susumu, Sato Eigo, Nakamura Noriaki, Iwai Takahisa, Mori Akira, Tanaka Junji, Imamura Masayaki
Department of Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
J Am Coll Surg. 2003 Feb;196(2):243-9. doi: 10.1016/S1072-7515(02)01616-2.
Resection of the IVC is required when a liver tumor invading the IVC is completely removed. The purpose of this study was to evaluate the clinical significance of hepatectomy combined with IVC resection and reconstruction with an ePTFE graft for treatment of invasive liver tumors and to discuss the validity of this surgery.
Eleven selected patients with liver tumors underwent various types of hepatectomy with retrohepatic IVC resection, followed by IVC reconstruction. The postoperative courses, clinicopathologic features of the tumors, operative procedures, and outcomes of the patients were studied.
Ten of 11 patients did not require an active ventriculovenous bypass using a biopump. Invasion to the IVC was histologically proved in 9 of the 11 patients. After reconstruction, all artificial vessel grafts maintained patency throughout the observation period. Four patients are still alive with cancer-free status ranging from approximately 11 years to 5 months. One-year, 3-year, and 5-year survival rates were 63.6%, 38.2%, and 25.5%, respectively, with a 50% survival of 29 months.
IVC resection and its reconstruction with ePTFE for treatment of liver tumors was safely performed on 11 selected patients with a 50% survival of 29 months. Patency of the graft was maintained for the longterm without infectious complications. This surgical procedure is indicated in some select patients in whom IVC invasion is extensive.
当侵袭下腔静脉(IVC)的肝肿瘤被完全切除时,需要切除IVC。本研究的目的是评估肝切除术联合IVC切除并用ePTFE移植物进行重建治疗侵袭性肝肿瘤的临床意义,并探讨该手术的有效性。
11例选定的肝肿瘤患者接受了各种类型的肝切除术并伴有肝后IVC切除,随后进行IVC重建。研究了患者的术后病程、肿瘤的临床病理特征、手术操作及结果。
11例患者中有10例不需要使用生物泵进行主动脑室静脉分流。11例患者中有9例经组织学证实侵袭IVC。重建后,在整个观察期内所有人工血管移植物均保持通畅。4例患者仍存活,无癌状态持续时间约为11年至5个月。1年、3年和5年生存率分别为63.6%、38.2%和25.5%,中位生存期为29个月。
对11例选定患者安全地实施了IVC切除并用ePTFE进行重建以治疗肝肿瘤,中位生存期为29个月。移植物长期保持通畅,无感染并发症。该手术适用于一些IVC侵袭广泛的选定患者。